NettetINTA’s 2024 Annual Meeting Live is approaching this May! Join the following Table Topic event if you seek to learn early career business development… Nettet30. mar. 2024 · Intas Pharmaceuticals Limited, based in Ahmedabad was founded in 1984 and has a revenue of $340 million in 2024. It has 13 commercialized biosimilars including Docetaxel and Paclitaxel. This pharma company in India has its R&D department in the field of chronic disease of oncology (cancer), rheumatology, auto-immune, nephrology, …
Intapp, Inc. (INTA) Stock Price, Quote & News - Stock …
NettetOur Offerings Upcoming IPOs Invest In Best Worst list Issue Opens On 07 Apr 2024 Closes On 07 Apr 2024 Money Payable On Application NaN Allotment NaN Project Cost (Cr.) Post Issue Equity Share Capital (Cr.) Issue Price (D) Further Multiples of: Projects Promoted By Listing At Registrar to the Issue - Phone - Fax - Email - Website - Nettet16. sep. 2024 · Its share prices hit a high of Rs 198.50 on BSE. February 16, 2024 12:54 PM IST Mankind Pharma to acquire two brands from Dr Reddy's Laboratories As per the terms of the definitive agreement... prime auto group westwood ma
Intas Pharmaceuticals to go for $4-billion deals in a month
Nettet10. apr. 2024 · Latest News Today: Breaking news on Business, Politics, Sports, Bollywood, Education, Science. Latest News on Share Market, IPO, India, Current … Nettet10. apr. 2024 · The Maximum Retail Price (MRP) of Eleftha will be Rs. 19,995 for the dose strength of 440 mg, which makes it ~65% more economical than the currently available options. Presently, the MRP of most of the trastuzumab brands in India ranges between Rs.58,000 to Rs.63,000 per 440 mg vial. NettetIndus Towers Limited Share Price Today, Stock Price, Live NSE News, Quotes, Tips – NSE India Equity As onIST (All price values in Order Book Qty Bid (₹) Ask (₹) Qty Buy Quantity - Sell Quantity - Series Symbol ISIN Status Date of Listing Basic Industry Symbol P/E Sectoral Index P/E Sectoral Index Securities Information Board Status Trading Status playguy october 2004